• Explore /
  • Poster
  • / Influence of hormone therapy timing intake on disease free survival (DFS) for patients with high-risk early breast cancer: Results of the UCBG-UNIRAD phase III randomized trial.

Influence of hormone therapy timing intake on disease free survival (DFS) for patients with high-risk early breast cancer: Results of the UCBG-UNIRAD phase III randomized trial.

Abstract Poster

Authors

null

Sylvie Giacchetti

APHP University Hopital Saint Louis, Senopole, Paris, France

Sylvie Giacchetti , Enora Laas , Thomas Bachelot , Jerome Lemonnier , Fabrice Andre , David A. Cameron , Judith Bliss , Sylvie Chabaud , Anne-Claire Hardy-Bessard , Magali Lacroix-Triki , Jean-Luc Canon , Marc Debled , Mario Campone , Paul H. Cottu , Florence Dalenc , Annabelle Ballesta , Frederique Madeleine Penault-Llorca , Fabien Reyal , Francis Lévi , Anne-Sophie Hamy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT01805271

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 546)

DOI

10.1200/JCO.2023.41.16_suppl.546

Abstract #

546

Poster Bd #

376

Abstract Disclosures

Similar Posters

First Author: Maria Vittoria Dieci

First Author: Yen-Shen Lu

First Author: Fatima Cardoso

First Author: Francesco Perrone